ENDRA Life Sciences Inc. — Cash Flow Charts
5 years of history · ending 2020-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-716.8% -$9M
$-11M
Free Cash Flow↓-722.6% -$10M
$-11M
Investing Cash Flow
$-75K
Financing Cash Flow↑+723.8% +$10M
$12M
Capex
$75K
Stock-Based Comp
$2M
Debt Repaid
—
D&A↑+53.0% +$34K
$99K
SBC Allocated Expense
$2M